CTOs on the Move

TriVascular

www.trivascular.com

 
TriVascular has pioneered numerous design and manufacturing technologies in pursuit of our commitment to providing optimal solutions for endovascular aortic repair (EVAR). TriVascular`s initial product offerings are novel endovascular grafts focused on significantly advancing EVAR. Building upon partnerships with thought leading clinicians worldwide, TriVascular`s products are designed to address unmet clinical needs and expand the pool of patients who are candidates for EVAR.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Funding

TriVascular raised $10M on 08/21/2015

Similar Companies

Viveve

Viveve provides women low risk, high reward medical procedures that promote personal health and wellness.

Propeller Health

Propeller is the leading digital platform for respiratory health management.Through sensors, mobile apps and services, Propeller helps reduce the cost of care while delivering better quality of life for individuals with chronic respiratory disease. Backed by Safeguard Scientifics, Social Capital, California HealthCare Foundation and other investors, Propeller Health is now working with organizations like Dignity Health, Wyckoff Heights Medical Center, Amerigroup Florida and the City of Louisville. Company recognition includes TEDMED Innovation Showcase, White House Champion of Change and Bluetooth Breakthrough Product awards. The system has been featured in The Economist, Washington Post, Fast Company, Wired and Scientific American.

Healthline Med

Healthline Med is a Baldwin Park, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Vesper Medical

Vesper Medical is committed to developing safe, efficacious and easy-to-use products for patients with deep venous disease and the physicians who treat them.

Zenflow

Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign prostatic hyperplasia (BPH). Millions of patients do not see effective relief from drugs, yet decline to undergo an invasive surgical procedure with high risk of side effects such as sexual dysfunction.